Efficacy and safety of dinaciclib vs ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia

P Ghia, L Scarfò, S Perez, K Pathiraja, M Derosier, K Small, CMC Sisk, N Patton

Research output: Contribution to journalArticlepeer-review

Abstract

No abstract available
Original languageEnglish
Pages (from-to)1876-1878
Number of pages3
JournalBlood
Volume129
Issue number13
DOIs
Publication statusPublished - 2017

Fingerprint Dive into the research topics of 'Efficacy and safety of dinaciclib vs ofatumumab in patients with relapsed/refractory chronic lymphocytic leukemia'. Together they form a unique fingerprint.

Cite this